Staff Reports
The pharmaceutical giants are experiencing a collective meltdown, and it’s utterly delightful to witness. While the power players of Big Pharma are dusting off their panic buttons, Americans can rest assured that an overdue reckoning is on the horizon. If justice unfolds as it should, they might just end up losing more than their precious influence over the nation’s health.
A recent account from an advisor to Robert F. Kennedy Jr. suggests that the CEOs of the five biggest pharmaceutical companies held a frantic teleconference right after the election results. They were strategizing on how to keep their grip on U.S. healthcare amid the fiscal storm brought about by former President Trump’s significant victory. It’s amusing to see these executives scrambling, knowing that a Trump administration has made it clear that it intends to disrupt their established control and financial schemes.
YOU HEAR THAT BIG PHARMA??!
PANIC‼️
According to NJ Mayor and Advisor to RFK Jr, Jamel Holley, five CEOs of pharmaceutical companies held an emergency teleconference at 1 PM.
A lawyer has confirmed that everyone is having a MELTDOWN and is in a state of panic!
They Know RFK… pic.twitter.com/exkZ4cIkrc
— Alma Gentil (@Chinoy200096633) November 6, 2024
Kennedy, no stranger to challenging corporate interests in health policy, is likely to take the reins under Trump’s administration. His approach to overhauling federal health agencies, including the FDA and CDC, is creating quite an unsettling atmosphere for these pharma bigwigs. They’re worried because Kennedy is not merely threatening to shake things up; he’s poised to dismantle the very systems they’ve manipulated for years, and the anxiety coursing through the corporate boardrooms is palpable.
What could possibly have these executives so riled up? RFK Jr. has made it known that he plans to wield a figurative blowtorch against the agencies that he believes are corrupted. His agenda includes dismantling the nutrition department of the FDA, which he claims is failing to ensure that American kids aren’t exposed to a cornucopia of unhealthy ingredients. He rightfully asks why certain cereals can contain a laundry list of ingredients here in the U.S. while their Canadian counterparts are streamlined with only a few. It seems the corruption needs to go, and Kennedy is convinced that cleaning house isn’t just possible—it’s necessary.
Even the broader biomedical industry is feeling the heat. With Kennedy’s “Make America Healthy Again” platform, he aims to eliminate dangerous chemicals in foods and crack down on ultra-processed options. This potential overhaul has sent ripples of fear among public health researchers and influencers who have thrived under the current system. Critics have voiced concerns that Kennedy could unleash chaos upon the vaccination initiative. It appears the health establishment is more worried not about maintaining public health but rather about keeping their cushy positions intact.
As Washington shifts gears, it’s hard not to appreciate the high-stakes drama unfolding. The arrival of a Trump administration might just usher in a new era of accountability, one where Americans can stand up to the pharmaceutical overlords and demand genuine care for their health rather than fuzzy science and profit-driven motives. Whatever happens, the tension brewing in the corridors of power is a welcome sign that change is on the horizon, and the chaos in the boardrooms of Big Pharma is a satisfying sight.
